- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06394583
LUS AT BIRTH IN INFANTS BORN BEFORE 26 WEEKS (MINI-LUS)
April 30, 2024 updated by: Almudena Alonso Ojembarrena, Andaluz Health Service
DESCRIPTION OF THE LUNG ULTRASOUND PATTERN IN INFANTS UNDER 26 WEEKS OF GESTATION: A NATIONAL MULTICENTER STUDY
All infants born before 26 weeks born in a hospital included in the registry will receive a LU at birth, before the first dose of surfactant.
We will register as well the length of IMV, NIV or the need of IMV in the whole sample.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
150
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Infants born before 26 weeks in any of the centers included in the registry.
Description
Inclusion Criteria:
- Infants born before 26 weeks at any of the participant hospitals.
Exclusion Criteria:
- received surfactant before LU
- redirection of care
- severe malformations of cromosomopathies
- unable to perform LU
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Description of LU patterns
Time Frame: at birth
|
at birth
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
need of IMV
Time Frame: during NICU admission
|
during NICU admission
|
|
length of IMV
Time Frame: during NICU admission
|
during NICU admission
|
|
length of NIV
Time Frame: during NICU admission
|
during NICU admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 30, 2024
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
December 1, 2029
Study Registration Dates
First Submitted
April 28, 2024
First Submitted That Met QC Criteria
April 30, 2024
First Posted (Actual)
May 1, 2024
Study Record Updates
Last Update Posted (Actual)
May 1, 2024
Last Update Submitted That Met QC Criteria
April 30, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NEO-LUS-24-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Each investigator will review only the data from their own hospital.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.